Genalyte is a tech-enabled, full service CAP accredited and CLIA certified laboratory. We perform the majority of tests with our rapidly deployable mobile laboratory in under 30 minutes. Our central lab handles tests that cannot be performed onsite. All results are run through CloudLab, our proprietary tele-health platform, for quality oversight and monitoring by Clinical Lab Scientists.
Core to our mobile capabilities is the Maverick platform, which has unprecedented serological testing functionality - permitting up to 64 simultaneous immunoassays on whole blood in 15 minutes. The platform achieved FDA clearance in Oct 2019. In these unprecedented times, we have developed a rapid COVID-19 serology test for IgG and IgM antibodies, while simultaneously including flu and other respiratory illnesses for differential diagnosis.
For more information, visit www.genalyte.com.
Core to our mobile capabilities is the Maverick platform, which has unprecedented serological testing functionality - permitting up to 64 simultaneous immunoassays on whole blood in 15 minutes. The platform achieved FDA clearance in Oct 2019. In these unprecedented times, we have developed a rapid COVID-19 serology test for IgG and IgM antibodies, while simultaneously including flu and other respiratory illnesses for differential diagnosis.
For more information, visit www.genalyte.com.
Location: United States, California, San Diego
Employees: 51-200
Phone: 8589561200
Total raised: $98M
Founded date: 2007
Investors 7
| Date | Name | Website |
| - | Khosla Ven... | khoslavent... |
| - | CLI Ventur... | cli.ventur... |
| - | Boutique V... | boutiquevc... |
| - | Biobrit | biobrit.co... |
| - | Caruso Ven... | carusovent... |
| - | FusionX Ve... | fusionxven... |
| - | TEL Ventur... | tel.com/ab... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 12.01.2021 | - | $50M | - |
| 22.11.2016 | - | $36M | Khosla Ven... |
| 30.03.2012 | Series B | $12M | - |
Mentions in press and media 20
| Date | Title | Description |
| 12.01.2021 | Genalyte Finds $50M Funding | San Diego-based Genalyte, a developer of laboratory diagnostics and analytics products, announced on Monday that it has raised $50M in a funding round. The funding was led by Verily, an Alphabet company, and also included Provenio Capital, ... |
| 12.01.2021 | Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform | Diagnostic and Analytics Company Aims to Revolutionize Laboratory Testing and Analytics Genalyte, a leading diagnostics and analytics company, announced the closure of $50 million in financing. Genalyte’s Maverick Diagnostic System (MDS) us... |
| 11.01.2021 | Genalyte has announced an oversubscribed $50M funding round to expand its testing menu and rapidly deploy its Maverick platform in clinical and retail settings | - |
| 11.01.2021 | Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform | |
| 15.10.2020 | Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test | |
| 14.12.2017 | Genalyte hires Facebook and Google exec Kevin Lo as company president | Khosla-backed one drop blood test startup Genalyte has hired former Facebook exec Kevin Lo as president of the company. Lo comes to Genalyte after leading “connectivity efforts” at Facebook “for the four billion people not online, and the 1... |
| 22.11.2016 | Theranos Competitor Genalyte Nabs $35M for One-Drop Blood Test | Genalyt, a San Diego, CA based startup has raised $36 million in funding led by Khosla Ventures and Redmile Group to expand its one-drop blood test platform, Maverick™ Detection System.Founded in 2007, the Theranos competitor leverages prop... |
| 21.11.2016 | Genalyte raises $36 million from Khosla for its one-drop blood test | Theranos competitor Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group. The San Diego-based startup leverages lab-on-a-chip technology it says can run through up to 128 d... |
| 21.11.2016 | Genalyte Raised $36M in Financing | Genalyte, Inc., a San Diego, CA-based biotech company, raised an additional $36m in its latest financing round. The round was led by Khosla Ventures and Redmile Group. The company intends to use the funds to continue to develop the platform... |
| 21.11.2016 | Genalyte Finds $36M | San Diego-based biotech company Genalyte said this morning that it has raised $36M in a new funding round, for its efforts to develop a microchip-based testing platform. The funding was led by Khosla Ventures and Redmile Group. Genalyte is ... |
Show more